
The results from zzso studies using zzso tumor models show that the combination of zzso zzso and zzso zzso is highly zzso Phase I studies in patients with advanced solid tumors indicate that 60 zzso of zzso administered as a zzso intravenous infusion followed by a daily intravenous zzso of 300 zzso of zzso on days 1 through 5 is the recommended dose for phase II zzso zzso results from another phase I study using a continuous infusion regimen for zzso suggest that 85 zzso of zzso administered as a zzso intravenous infusion followed by continuous infusion of 750 zzso per day of zzso on days 1 through 5 may be the recommended dose for phase II zzso As expected, zzso zzso included zzso and zzso zzso phase zzso and II studies are investigating the combination of zzso with continuous infusion of zzso in patients with zzso breast cancer and with zzso zzso and continuous infusion of zzso with and without zzso in patients with head and neck zzso zzso results are encouraging and warrant further zzso 

